Outcomes of patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitors (ICIs): Associations with age, race, sex and smoking history. Makrakis, D., Talukder, R., Carril, L., de Kouchkovsky, I., Park, J. J., Bilen, M., McKay, R. R., Agarwal, N., Zakharia, Y., Devitt, M. E., Pinato, D., Hoimes, C. J., Gartrell, B., Tripathi, A., Bamias, A., Drakaki, A., Murgic, J., Di Lorenzo, G., Grivas, P., Khaki, A. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.e16526

View details for Web of Science ID 000708120302226